Related Experiment Videos
Balloon angioplasty in acute and chronic coronary artery disease
1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905.
Insights
Percutaneous transluminal coronary angioplasty (PTCA) is a widely used procedure for coronary artery disease. While successful in ideal cases, outcomes vary with disease severity, and challenges like restenosis and comparisons to surgery remain key research areas.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) has seen significant growth and is indicated for various coronary conditions.
- Selection criteria encompass single-vessel, multivessel disease, stable/unstable angina, and acute myocardial infarction.
Purpose of the Study:
- To review the current status, outcomes, and unresolved issues in percutaneous transluminal coronary angioplasty.
- To assess the impact of patient and angiographic factors on PTCA success rates.
Main Methods:
- Review of existing literature and clinical data on percutaneous transluminal coronary angioplasty.
- Analysis of success rates and complication profiles based on lesion complexity and patient characteristics.
Main Results:
- High success rates (>90%) with low morbidity/mortality are achievable in ideal lesions.
- Outcomes are less favorable in severe, diffuse multivessel disease, though PTCA remains a viable option for palliation or complete revascularization.
- Restenosis affects approximately 30% of treated lesions.
Conclusions:
- PTCA is an effective treatment for coronary artery disease, with outcomes dependent on lesion and patient factors.
- Key unresolved issues include the comparative effectiveness of PTCA versus coronary artery bypass grafting surgery, restenosis rates, and the need for standardized training and certification.
Abstract:
Percutaneous transluminal coronary angioplasty has grown exponentially since its introduction. Currently, selection criteria include single-vessel and multivessel disease, stable and unstable angina, and acute infarction. The outcome depends on specific patient and angiographic characteristics. In ideal lesions, success rates should be greater than 90%, with low morbidity and mortality. With more severe and diffuse multivessel disease, success rates are lower and complication rates are higher. In these cases, percutaneous transluminal coronary angioplasty still offers a reasonable option, provided complete revascularization can be achieved or the angina-producing lesion dilated. Numerous issues remain unresolved, including (1) the role of percutaneous transluminal coronary angioplasty vs coronary surgery (currently being tested), (2) restenosis, which occurs in approximately 30% of treated lesions, and (3) organizational adjustments such as training and certification to maintain high standards of care.